Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
DOI:
https://doi.org/10.47338/jns.v2.44Keywords:
Down's syndrome, Duodenal atresia, Transient myeloproliferative disorderAbstract
Down's syndrome (DS) is associated with duodenal atresia (DA) in about 8-10% of cases. Transient Myeloproliferative Disorder (TMD)/Acute Myeloid Leukemia (AML) is also associated with the trisomy 21 mutation. The occurrence of the two conditions together complicates the diagnosis and surgical management of the DA. We discuss the technical aspects of management of the DA in this clinical setting.
Downloads
Download data is not yet available.
Metrics
Metrics Loading ...
Published
2013-04-07
How to Cite
1.
Burjonrappa SC. Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly. J Neonatal Surg [Internet]. 2013Apr.7 [cited 2025Feb.14];2(3):32. Available from: https://jneonatalsurg.com/index.php/jns/article/view/44
Issue
Section
Case Report
License
Copyright (c) 2013 Journal of Neonatal Surgery

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.